title: Treatment with niacin lowers ADMA.
authors.forename: Sabine
authors.initials: S
authors.lastname: Westphal
authors.forename: Katrin
authors.initials: K
authors.lastname: Borucki
authors.forename: Claus
authors.initials: C
authors.lastname: Luley
authors.forename: Jens
authors.initials: J
authors.lastname: Martens-Lobenhoffer
authors.forename: Stefanie M
authors.initials: SM
authors.lastname: Bode-Böger
mesh_terms: D000328:Adult; D000368:Aged; D001120:Arginine / Q000031:analogs & derivatives* / Q000097:blood / Q000187:drug effects; D050197:Atherosclerosis / Q000097:blood* / Q000517:prevention & control; D015415:Biomarkers / Q000097:blood; D005260:Female; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009525:Niacin / Q000627:therapeutic use*; D019001:Nitric Oxide Synthase / Q000037:antagonists & inhibitors; D012307:Risk Factors; D016896:Treatment Outcome
chemical_list: D015415:Biomarkers; D000960:Hypolipidemic Agents; D009525:Niacin; C018524:N,N-dimethylarginine; D001120:Arginine; D019001:Nitric Oxide Synthase